" "

King Charles III diagnosed with cancer, commences treatment-palace confirms

0 101

Buckingham Palace issued a statement on Monday revealing that King Charles III has been diagnosed with cancer. The undisclosed type of cancer was detected during medical attention for an enlarged prostate just over a week ago. It is clarified that the cancer is unrelated to the previously treated prostate issue.

The 75-year-old monarch was discharged a week ago following the treatment for the non-cancerous enlarged prostate. However, during this period, a separate health concern was identified through diagnostic tests, leading to the diagnosis of cancer. Buckingham Palace announced that King Charles III has initiated a schedule of regular treatments, resulting in the postponement of public-facing duties while maintaining his official responsibilities.

Expressing gratitude to the medical team for swift intervention, the palace stated that the king remains optimistic about his treatment, emphasizing his decision to share the diagnosis to prevent speculation and contribute to public understanding of cancer. Charles, who ascended to the throne last year, had a non-cancerous growth removed from his face in 2008.

The royal family, including Charles’ daughter-in-law Kate, Princess of Wales, who recently underwent an unspecified abdominal surgery, and his son William, Prince of Wales, are coping with the situation. Prince Harry, Duke of Sussex, is reported to have spoken with his father about the diagnosis and plans to visit the UK in the coming days.

British Prime Minister Rishi Sunak extended well wishes for a full and speedy recovery, expressing confidence in King Charles III’s return to full strength. International leaders, including President Biden in Las Vegas and the State Department spokesperson Vedant Patel in Washington, conveyed sympathies to the royal family, highlighting the global concern for the monarch’s health.

About Author

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © Muslim Media Corporation, New York. All rights reserved.